Singapore · Delayed Price · Currency is SGD The Trendlines Group Company Description
The Trendlines Group Ltd. is an innovation commercialization company and a private equity and venture capital firm specializing in incubation, seed, start-up, early venture and late venture investments.
The firm seeks to invest in food, medtech, clean technology, agrifood, agritechnology, lifesciences with a focus on medical devices, biotechnology, and pharmaceuticals, security, medical, and information technology companies.
It considers investments in Israel and Singapore. The firm offers business incubation, partner and channel development, market strategies, business plans, research and development and commercialization activities, business development, finance and funding strategies, administrative services and marketing communications services to entrepreneurs.
The firm prefers to exit its investments through merger and acquisition transactions, listing on public stock exchanges, or other dispositions of holdings.
It leverages its own capital with government funding to mitigate risk in creating and developing new businesses.
It is involved in all aspects of its portfolio companies from technology development to business building.
The Trendlines Group Ltd. was founded in 1993 and is based in M.P. Misgav, Israel with additional offices in Tel Aviv, Israel; Beijing, China; and Singapore, Singapore.
| Country | Israel |
| Founded | 1993 |
| Industry | Investors, not elsewhere classified |
| Employees | 23 |
| CEO | Haim Brosh |
Contact Details
Address: The Trendlines Building M P Misgav, 2017400 Israel | |
| Phone | 972 72 260 7000 |
| Website | trendlines.com |
Stock Details
| Ticker Symbol | 42T |
| Exchange | Singapore Exchange - Catalist |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 6799 |
Key Executives
| Name | Position |
|---|---|
| Haim Brosh | Chief Executive Officer |
| Igor Vatenmacher | Chief Financial Officer |
| Irit Shemesh-Catz | Chief Operating Officer |
| Shira Zimmerman | Head of Investor Relations |